Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Seber

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|February 26, 1999
Risk factors for severe hemorrhagic cystitis following BMTA Seber, X O Shu, T Defor, et al.
Biometrics|September 12, 2001
Capture-recapture, epidemiology, and list mismatches: several listsA J Lee, G A Seber, J K Holden, et al.
Journal - Forensic Science Society|March 1, 1987
A stratified approach to the compilation of blood group frequency surveysJ S Buckleton, K A Walsh, G A Seber, et al.
Annals of Human Biology|January 1, 1987
Blood groups and other genetic markers in New Zealand Europeans and MaorisD G Woodfield, L A Simpson, G A Seber, et al.
Forensic Science International|October 1, 1986
Comments on the use of blood marker frequency dataK A Walsh, M E Lawton, J S Buckleton, et al.
Medical and Pediatric Oncology|February 5, 2000
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trialA S Petrilli, L S Dantas, M C Campos, et al.
Transplantation Proceedings|February 1, 1997
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidityS J Noga, G B Vogelsang, A Seber, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactionsE J Fuchs, A Seber, V Altomonte, et al.
Journal of Hematotherapy|May 23, 1998
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftmentS J Noga, A Seber, J M Davis, et al.
Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|February 26, 1999
Risk factors for severe hemorrhagic cystitis following BMTA Seber, X O Shu, T Defor, et al.
Biometrics|September 12, 2001
Capture-recapture, epidemiology, and list mismatches: several listsA J Lee, G A Seber, J K Holden, et al.
Journal - Forensic Science Society|March 1, 1987
A stratified approach to the compilation of blood group frequency surveysJ S Buckleton, K A Walsh, G A Seber, et al.
Annals of Human Biology|January 1, 1987
Blood groups and other genetic markers in New Zealand Europeans and MaorisD G Woodfield, L A Simpson, G A Seber, et al.
Forensic Science International|October 1, 1986
Comments on the use of blood marker frequency dataK A Walsh, M E Lawton, J S Buckleton, et al.
Medical and Pediatric Oncology|February 5, 2000
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trialA S Petrilli, L S Dantas, M C Campos, et al.
Transplantation Proceedings|February 1, 1997
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidityS J Noga, G B Vogelsang, A Seber, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactionsE J Fuchs, A Seber, V Altomonte, et al.
Journal of Hematotherapy|May 23, 1998
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftmentS J Noga, A Seber, J M Davis, et al.
Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.
Pageof 4